CeriBell, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CeriBell, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $2.01M, a 311.27% increase year-over-year.
- CeriBell, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $251.00K, a 112.71% increase year-over-year.
- CeriBell, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $334.00K, a 413.85% increase year-over-year.
- CeriBell, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $488.00K, a 140.39% increase year-over-year.
- CeriBell, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.13M, a 21.14% increase from fiscal 2023.
- CeriBell, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $932.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $2.01M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $251.00K 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $1.13M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $334.00K 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $488.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $118.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $932.00K 10-K · filed 2025-02-25 | |
| 2023-09-30 | $65.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $203.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $376.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |